Fructose and Its Impact on Uric Acid Levels in Humans: A Systematic Review and Meta-Analysis of Clinical Trials from PubMed Database

Main Article Content

Baharuddin Baharuddin
http://orcid.org/0000-0002-7079-5748
Lilies Handayani

Abstract


Worldwide fructose consumption continues to increase annually. It is well-established that high-dose fructose consumption can lead to metabolic disorders in humans. One of the indicators affected is uric acid, with several studies reporting increased uric acid levels following fructose intake. This study employs a systematic literature review and meta-analysis approach. We conducted a literature search exclusively in the PubMed database using keywords related to hyperuricemia, uric acid, fructose, and human health. The search was based on the PICO strategy: human health (population), fructose (intervention), glucose (comparison), uric acid (outcome). Nine eligible documents were analyzed for meta-analysis out of 81 documents retrieved from the PubMed database. Based on the Random Effects model (RE), the Standardized Mean Difference (SMD) value was -0.37 (95% CI; -1.34 to 0.59). The RE value crosses the vertical 0 line. Across various clinical studies, fructose consumption did not significantly show negative effects. Although some studies demonstrated dynamic changes, they remained within the normal range. However, these conclusions cannot be directly generalized due to limited knowledge on the long-term effects of fructose. Additionally, aspects such as dosage, duration, type of fructose, anthropometry, and subject characteristics need further attention and analysis in each fructose-related study, as they may be significant factors contributing to variations in study outcomes.

Article Details

How to Cite
1.
Baharuddin B, Handayani L. Fructose and Its Impact on Uric Acid Levels in Humans: A Systematic Review and Meta-Analysis of Clinical Trials from PubMed Database. SANITAS [Internet]. 7Jan.2025 [cited 23Feb.2025];15(2):88-01. Available from: https://sanitas.e-journal.id/index.php/SANITAS/article/view/507
Section
Nutrition and Dietetics

References

Tero-Vescan A, Ștefănescu R, Istrate TI, Pușcaș A. Fructose-induced hyperuricaemia – protection factor or oxidative stress promoter? Nat Prod Res. 2024 Mar 24;1–13.

Caliceti C, Calabria D, Roda A, Cicero AFG. Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. Nutrients. 2017 Apr;9(4):395.

Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Higgins JPT, Thomas J, editors. Hoboken, NJ: Wiley-Blackwell; 2019. 736 p.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71.

Barker TH, Stone JC, Sears K, Klugar M, Leonardi-Bee J, Tufanaru C, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023 Mar;21(3):478.

Nested Knowledge. Nested Knowledge. 2024 [cited 2024 Jun 20]. Nested Knowledge Features. Available from: https://about.nested-knowledge.com/

Vieira AF, Moritz CEJ, Ramis TR, Boeno FP, Dos Santos GC, Lisboa SC, et al. Chronic aerobic exercise prevents high-fructose diet-induced impairment in blood pressure in healthy young adults: a double-blind, randomised clinical trial. Br J Nutr. 2022 Nov 28;128(10):1975–89.

Angelopoulos TJ, Lowndes J, Sinnett S, Rippe JM. Fructose containing sugars do not raise blood pressure or uric acid at normal levels of human consumption. J Clin Hypertens Greenwich Conn. 2015 Feb;17(2):87–94.

Nguyen NU, Dumoulin G, Henriet MT, Regnard J. Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res Horm Stoffwechselforschung Horm Metab. 1995 Mar;27(3):155–8.

Sievenpiper JL, Chiavaroli L, De Souza RJ, Mirrahimi A, Cozma AI, Ha V, et al. ‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr. 2012 Aug 14;108(3):418–23.

Sievenpiper JL, De Souza RJ, Cozma AI, Chiavaroli L, Ha V, Mirrahimi A. Fructose vs. glucose and metabolism: do the metabolic differences matter? Curr Opin Lipidol. 2014 Feb;25(1):8–19.

Pérez S. The structure of sucrose in the crystal and in solution. In: Mathlouthi M, Reiser P, editors. Sucrose: Properties and Applications [Internet]. Boston, MA: Springer US; 1995 [cited 2024 May 23]. p. 11–32. Available from: https://doi.org/10.1007/978-1-4615-2676-6_2

Shallenberger RS. Structure Reactions and Properties of Sugars. In: Shallenberger RS, editor. Taste Chemistry [Internet]. Boston, MA: Springer US; 1993 [cited 2024 May 23]. p. 153–88. Available from: https://doi.org/10.1007/978-1-4615-2666-7_6

Yu S, Li C, Ji G, Zhang L. The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease. Front Pharmacol [Internet]. 2021 Nov 18 [cited 2024 May 23];12. Available from: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.783393/full

Krause N, Wegner A. Fructose Metabolism in Cancer. Cells. 2020 Dec 8;9(12):2635.

Lelis DDF, Andrade JMO, Almenara CCP, Broseguini-Filho GB, Mill JG, Baldo MP. High fructose intake and the route towards cardiometabolic diseases. Life Sci. 2020 Oct;259:118235.

Masajtis-Zagajewska A, Majer J, Nowicki M. Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome. J Renin-Angiotensin-Aldosterone Syst JRAAS. 2021;2021:2214978.

Emmerson BT. Effect of oral fructose on urate production. Ann Rheum Dis. 1974 May 1;33(3):276–80.